SEC filing record
Primary Source · SEC.gov

Moximed, Inc

2024 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2024-08-20Last filing 2024-08-20

Raised

$63M

Investors

35

Min Invest

$1

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Moximed, Inc is a Delaware corporation that filed a Form D with the SEC on August 20, 2024 in the Other Health Care industry group. The offering claims Rule 506(b) and covers equity. Moximed, Inc reported $62,712,862 sold from 35 investors of a $91,046,192 total offering as of the Form D filed August 20, 2024. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $1. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 46602 Landing Pkwy, Fremont, CA 94538.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001433163
Entity NameMoximed, Inc
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address46602 Landing Pkwy, Fremont, CA 94538
Phone(510) 887-3300
Former NamesEXPLORAMED NC4 INC (until June 12, 2008)
Industry / Fund TypeOther Health Care
Securities TypeEquity
First Sale DateAugust 7, 2024
Filing DateAugust 20, 2024
Accession Number0001433163-24-000003
Total Offering Amount$91,046,192
Total Amount Sold$62,712,862
Amount Remaining$28,333,330
Total Investors35
Non-Accredited InvestorsNone
Minimum Investment$1
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeDecline to Disclose
State (Issuer Address)CA
Amendment Count3 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

1

latest Aug 20, 2024

Critical / warning

0 / 0

1 watch · 0 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

2

lapsed

Latest event New filer · Aug 20, 2024

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 filing event with values and deltas, latest 2024-08-20, and alerts on the next one
  • 2 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Item 3 changed on the Form D filed 2024-08-20: 8 related persons added and 8 removed against the filing of 2017-03-31; 9 now listed. The names are in the Terminal feed.

Christopher Gleason

Executive Officer · Fremont, CA

David van Meter

Director · Fremont, CA

Michael Wasserman

Director · Fremont, CA

Matt McAviney

Director · Fremont, CA

Joshua Makower

Director · Fremont, CA

Anton Clifford

Executive Officer · Fremont, CA

David Amerson

Director · Fremont, CA

James Leech

Executive Officer · Fremont, CA

Shahzad Malik

Director · Fremont, CA

Questions About Moximed, Inc

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Moximed, Inc?

Moximed, Inc is a Delaware corporation that filed a Form D with the SEC on August 20, 2024 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.

Is Moximed, Inc legit?

AltStreet does not rate legitimacy; it reports the public record. Moximed, Inc filed a Form D with the SEC on August 20, 2024 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $62,712,862 sold to 35 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Moximed, Inc registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Moximed, Inc claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Moximed, Inc raised?

Moximed, Inc reported $62,712,862 sold from 35 investors of a $91,046,192 total offering as of the Form D filed August 20, 2024.

Who can invest in Moximed, Inc?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $1.

What is the minimum investment in Moximed, Inc?

The Form D lists $1 as the minimum investment accepted from any outside investor as of August 20, 2024. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling Moximed, Inc and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Moximed, Inc?

The Form D lists 9 related persons: Christopher Gleason, executive officer; David van Meter, director; Michael Wasserman, director; Matt McAviney, director; Joshua Makower, director; Anton Clifford, executive officer; David Amerson, director; James Leech, executive officer, and 1 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Moximed, Inc located?

The issuer's address on its SEC filings is 46602 Landing Pkwy, Fremont, CA 94538. Its phone number of record is 510-887-3300. It is organized under the laws of Delaware.

How long is the Moximed, Inc offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is Moximed, Inc's revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.